Text Size

Imaging Techniques in Body MRI

This study is currently recruiting participants.
Verified March 2012 by Johns Hopkins University
Sponsor:
Information provided by (Responsible Party):
David A. Bluemke, Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00362557
First received: August 9, 2006
Last updated: March 28, 2012
Last verified: March 2012
History of Changes
  Purpose

Any patient already receiving a scheduled MR scan of the body for any clinical indication will be eligible for this program. If patients agree to participate in this program, it would require only a slightly longer examination time. This time would vary according to the body area/organ being visualized but would not exceed 30 minutes over the length of the clinical examination. Volunteers are eligible if they are willing to undergo an MR examination.

Patients would not be required to make any additional visits beyond their clinically-indicated visits. The study duration would vary according to the body area/organ visualized but would not exceed 30 minutes over the length of the clinical examination. Volunteers would be required to keep one study appointment to include one MR imaging examination.

There will be no interruption to the standard care given to patients who participate in this trial since the clinical portion of their examination will be completed prior to the study portion of the exam.


Condition Intervention
Clinically Indicated MR Imaging
 Device: MRI

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Imaging Techniques in Body MRI

Further study details as provided by Johns Hopkins University:

Primary Outcome Measures:
  • Magnetic resonance signal [ Time Frame: At time of MRI ] [ Designated as safety issue: No ]
    Magnetic resonance imaging acquires signal from the human body. The signal will be measured at the time of the patient study. The amount of signal change will be measured between subjects.


Estimated Enrollment: 1000
Study Start Date: September 2001
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: MRI
    Magnetic resonance imaging
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male or Female clinically scheduled to undergo MR Imaging at Johns Hopkins Medical Institutions

Exclusion Criteria:

  • Contraindications to MR Imaging
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00362557

Contacts
Contact: Tracy L McCracken, RN BSN CCRP 410-955-4924 tborman@jhmi.edu

Locations
United States, Maryland
Johns Hopkins Hospital Recruiting
Baltimore, Maryland, United States, 21287
Principal Investigator: David A Bluemke, MD PhD            
Sponsors and Collaborators
Johns Hopkins University
Investigators
Principal Investigator: David A Bluemke, MD PhD Johns Hopkins University
  More Information

No publications provided

Responsible Party: David A. Bluemke, Staff member, Johns Hopkins University
ClinicalTrials.gov Identifier: NCT00362557     History of Changes
Other Study ID Numbers: 01-02-07-05
Study First Received: August 9, 2006
Last Updated: March 28, 2012
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on May 23, 2013